Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 4414

Update on Pediatric Hyperkinetic Disorders: What Adult Neurologists Should Know

Wednesday, October 8, 2025
14:00 - 15:30 | Room TBD
Clinical

In this session, the faculty will discuss the spectrum of childhood-onset hyperkinetic disorders that continue into adulthood with focus on treatable disorders and indications for DBS.


Chairs:
Miryam Carecchio, Italy
Shekeeb Mohammad, Australia

Presenters:

Update on the Spectrum of Pediatric Hyperkinetic Disorders
Vrajesh Udani, India

Treatable Pediatric Hyperkinetic Disorders
Mohamed Babiker, United Arab Emirates

DBS: Who and When?
Giovanna Zorzi, Italy

CSPC Liaisons:
Manju Kurian, United Kingdom

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Discuss the spectrum of childhood-onset hyperkinetic disorders and continue into adulthood including paroxysmal (ATP1A3, ADCY5, KCNMA1) and dyskinesia-epilepsy spectrum disorders (GNAO1)
  2. Describe the spectrum of childhood-onset treatable hyperkinetic disorders and emerging precision therapies
  3. Approach diseases most amenable to deep brain stimulation and decide the ideal timing for DBS

Recommended Audience
Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level
Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice